Jefferies Cuts Target on Vivus (VVUS) after FDA CV Panel, Keeps Lowest Rating
Go back to Jefferies Cuts Target on Vivus (VVUS) after FDA CV Panel, Keeps Lowest Rating| Vivus, Inc. (NASDAQ: VVUS) | Delayed: 0.47 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.47 | 52 Week High | $1.85 | |||
| Open | $44.85 | 52 Week Low | $0.92 | |||
| Day High | $0.47 | P/E | N/A | |||
| Day Low | $0.47 | EPS | $-2.13 | |||
| Volume | 1,328 | |||||
